(3S,10R,13S)-17-(benzimidazol-1-yl)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,12,14,15-decahydrocyclopenta[a]phenanthren-11-one

C26H30N2O2 — CID 52938712

IUPAC(3S,10R,13S)-17-(benzimidazol-1-yl)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,12,14,15-decahydrocyclopenta[a]phenanthren-11-one
SMILESC[C@]12CC[C@H](O)CC1=CCC1C2C(=O)C[C@]2(C)C(n3cnc4ccccc43)=CCC12
InChIInChI=1S/C26H30N2O2/c1-25-12-11-17(29)13-16(25)7-8-18-19-9-10-23(26(19,2)14-22(30)24(18)25)28-15-27-20-5-3-4-6-21(20)28/h3-7,10,15,17-19,24,29H,8-9,11-14H2,1-2H3/t17-,18?,19?,24?,25-,26-/m0/s1
InChIKeyZFBVHMWTMSLBQS-VTXUGQQNSA-N
MW402.54 g/mol
LogP4.99
Rot. Bonds1

About (3S,10R,13S)-17-(benzimidazol-1-yl)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,12,14,15-decahydrocyclopenta[a]phenanthren-11-one

(3S,10R,13S)-17-(benzimidazol-1-yl)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,12,14,15-decahydrocyclopenta[a]phenanthren-11-one (PubChem CID 52938712) has the molecular formula C26H30N2O2 and a molecular weight of 402.54 g/mol. Its IUPAC name is (3S,10R,13S)-17-(benzimidazol-1-yl)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,12,14,15-decahydrocyclopenta[a]phenanthren-11-one.

Molecular Properties

Compound Name(3S,10R,13S)-17-(benzimidazol-1-yl)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,12,14,15-decahydrocyclopenta[a]phenanthren-11-one
PubChem CID52938712
Molecular FormulaC26H30N2O2
Molecular Weight402.54 g/mol
Exact Mass402.23
IUPAC Name(3S,10R,13S)-17-(benzimidazol-1-yl)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,12,14,15-decahydrocyclopenta[a]phenanthren-11-one
SMILESC[C@]12CC[C@H](O)CC1=CCC1C2C(=O)C[C@]2(C)C(n3cnc4ccccc43)=CCC12
InChIInChI=1S/C26H30N2O2/c1-25-12-11-17(29)13-16(25)7-8-18-19-9-10-23(26(19,2)14-22(30)24(18)25)28-15-27-20-5-3-4-6-21(20)28/h3-7,10,15,17-19,24,29H,8-9,11-14H2,1-2H3/t17-,18?,19?,24?,25-,26-/m0/s1
InChIKeyZFBVHMWTMSLBQS-VTXUGQQNSA-N
XLogP4.99
TPSA55.12 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds1
Heavy Atoms30
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500402.54
LogP ≤ 54.99
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (3S,10R,13S)-17-(benzimidazol-1-yl)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,12,14,15-decahydrocyclopenta[a]phenanthren-11-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (3S,10R,13S)-17-(benzimidazol-1-yl)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,12,14,15-decahydrocyclopenta[a]phenanthren-11-one?
The IUPAC name of (3S,10R,13S)-17-(benzimidazol-1-yl)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,12,14,15-decahydrocyclopenta[a]phenanthren-11-one (CID 52938712) is (3S,10R,13S)-17-(benzimidazol-1-yl)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,12,14,15-decahydrocyclopenta[a]phenanthren-11-one.
What is the SMILES notation for (3S,10R,13S)-17-(benzimidazol-1-yl)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,12,14,15-decahydrocyclopenta[a]phenanthren-11-one?
The canonical SMILES for (3S,10R,13S)-17-(benzimidazol-1-yl)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,12,14,15-decahydrocyclopenta[a]phenanthren-11-one is C[C@]12CC[C@H](O)CC1=CCC1C2C(=O)C[C@]2(C)C(n3cnc4ccccc43)=CCC12.
What is the InChIKey of (3S,10R,13S)-17-(benzimidazol-1-yl)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,12,14,15-decahydrocyclopenta[a]phenanthren-11-one?
The InChIKey is ZFBVHMWTMSLBQS-VTXUGQQNSA-N. The full InChI is InChI=1S/C26H30N2O2/c1-25-12-11-17(29)13-16(25)7-8-18-19-9-10-23(26(19,2)14-22(30)24(18)25)28-15-27-20-5-3-4-6-21(20)28/h3-7,10,15,17-19,24,29H,8-9,11-14H2,1-2H3/t17-,18?,19?,24?,25-,26-/m0/s1.
What are the key properties of (3S,10R,13S)-17-(benzimidazol-1-yl)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,12,14,15-decahydrocyclopenta[a]phenanthren-11-one?
(3S,10R,13S)-17-(benzimidazol-1-yl)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,12,14,15-decahydrocyclopenta[a]phenanthren-11-one has a molecular weight of 402.54 g/mol, XLogP of 4.99, 1 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (3S,10R,13S)-17-(benzimidazol-1-yl)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,12,14,15-decahydrocyclopenta[a]phenanthren-11-one is sourced from PubChem (CID 52938712), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).